| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |